Proactive Investors UK | Cellmid's midkine antibodies show effectiveness against cancer Proactive Investors UK “We have postulated for some time that MK antibodies would have anti-cancer activities, via multiple mechanisms of action, and it is pleasing to see this confirmed in our own studies with our proprietary MK antibodies.” Cellmid's cancer antibody ... |
